Condition: Coronary Microvascular Disease · Refractory Angina · Sponsor: Johannes Gutenberg University Mainz
Patients with refractory microvascular angina fulfilling the predefined inclusion and exclusion criteria will be enrolled in this randomized trial. The primary objective is to investigate whether the proportion of patients reporting an improvement in Canadian Cardiovascular Society (CCS) angina class (≥2 classes) is different at six months after implantation of a Coronary Sinus Reducer followed by optimal medical therapy (OMT) compared to OMT alone.
This description comes directly from the study's public registry record.
tommaso gori, PI · +496131172829 · tommaso.gori@unimedizin-mainz.de
Always discuss trial participation with your own doctor first.
| Center of Cardiology, Cardiology I, university hospital Mainz | Mainz, Rhineland-Palatinate, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04606459